Table 3: Comparison of Predictors of Zero vs Only One Reported CD4/VL Test(s), and Only One vs Two or More Reported CD4/VL Tests(s) Performed within 12 Months of HIV Diagnosis, from Log-Binomial Regression Models, in Jurisdictions Participating in the Never In Care Project*

Characteristic Number of Reported CD4 or Viral Load Tests Performed Within 12 Months of Diagnosis†
Zero vs Only 1 CD4/VL Test(s)(N=5,228) Only 1 CD4/VL vs 2 or More (N=11,544)*
Crude Prevalence Ratio (95% Confidence Interval) Adjusted Prevalence Ratio (95% Confidence Interval) Crude Prevalence Ratio (95% Confidence Interval) Adjusted Prevalence Ratio (95% Confidence Interval)
Race/Ethnicity§
Hispanic 1.2 (1.1-1.4) 1.2 (1.1-1.4) 1.0 (0.9-1.1) 1.0 (0.9-1.1)
American Indian/Alaska Native 1.8 (1.2-2.9) 1.8 (1.2-2.8) 0.7 (0.3-1.4) 0.8 (0.4-1.6)
Asian/Pacific Islander 1.2 (0.9-1.6) 1.2 (0.9-1.5) 0.7 (0.6-0.9) 0.9 (0.7-1.1)
Black, non-Hispanic 1.4 (1.3-1.5) 1.3 (1.2-1.5) 1.1 (1.1-1.2) 1.1 (1.0-1.1)
Multi-race 1.6 (1.4-2.0) 1.4 (1.2-1.7) 0.6 (0.5-0.7) 0.9 (0.7-1.1)
White, non-Hispanic Ref Ref Ref Ref
Age at Diagnosis § (Years)
<20 1.4 (1.2-1.6) 1.3 (1.1-1.5) 1.0 (0.8-1.3) 1.1 (0.9-1.3)
20-29 1.1 (1.0-1.3) 1.1 (1.0-1.2) 1.0 (0.9-1.1) 1.1 (1.1-1.3)
30-39 1.0 (0.9-1.1) 1.0 (0.9-1.1) 1.1 (1.0-1.2) 1.2 (1.1-1.3)
40-49 1.1 (1.0-1.2) 1.0 (0.9-1.2) 1.0 (0.9-1.1) 1.1 (1.0-1.2)
50+ Ref Ref Ref Ref
Gender
Male 1.0 (0.9-1.1) 1.0 (0.9-1.1) 1.0 (0.9-1.0) 1.1 (1.0-1.2)
Female Ref Ref Ref Ref
Health Jurisdiction
Indiana 1.0 (0.8-1.2) 0.8 (0.7-1.0) 2.9 (2.5-3.3) 2.8 (2.4-3.3)
New Jersey 0.9 (0.7-1.0) 0.7(0.6-0.8) 3.0 (2.6-3.5) 2.9 (2.4-3.4)
New York City 1.3 (1.1-1.5) 1.1 (.9-1.3) 1.0 (0.9-1.2) 1.0 (0.9-1.2)
Philadelphia 1.0 (0.9-1.2 .9 (0.8-1.1) 2.5 (2.2-2.9) 2.3 (2.0-2.7)
Washington Ref Ref Ref Ref
Risk Category§
IDU 0.9 (0.80-1.0) 0.9 (0.8-1.1) 1.7 (1.5-1.9) 1.4 (1.3-1.6)
MSM & IDU 0.8 (0.7-1.0) 1.0 (0.8-1.2) 1.7 (1.5-1.9) 1.2 (1.1-1.4)
Heterosexual Contact 1.0 (1.0-1.1) 0.9 (0.9-1.0) 1.1 (1.0-1.1) 1.2 (1.1-1.3)
Other 1.1 (0.7-1.9) 1.3 (0.9-2.1) 2.3 (1.5-3.4) 1.5 (1.1-2.3)
Undetermined 1.1 (1.0-1.2) 1.3 (1.1-1.4) 2.1 (1.9-2.3) 1.2 (1.1-1.4)
MSM Ref Ref Ref Ref

* Among adults diagnosed from December 1, 2006-December 31, 2008, excluding all deaths during the first 12 months after diagnosis.
† Since 2005, two jurisdictions have had mandatory reporting of all CD4 and all VL values (Indiana, New York City) and two others have had mandatory reporting of all VL values and CD4 values below a threshold (Philadelphia, CD4 ≤_350 cells/mm3 and <25% of total lymphocytes and New Jersey, CD4 <200 cells/mm3). Washington has had reporting of all CD4 and all VL values since 2006; CD4 and viral load tests on the same date were counted as one test.
§ Age, race/ethnicity, or risk was missing for some individuals; MSM: man who has sex with men; IDU: injection drug user.